Pay vs Performance Disclosure, Table

Pay Versus Performance Table

As required by SEC rules, the following table summarizes certain information intended to illustrate the relationship between executive compensation “actually paid” and our financial performance in the last five fiscal years.

“Compensation actually paid,” as calculated pursuant to SEC disclosure rules, differs from the total compensation reported in the Summary Compensation Table in the applicable year due to the impact of changes in our stock price as well as the achievement of the underlying vesting conditions with respect to our equity awards, while compensation reported in the Summary Compensation Table calculates equity awards based on the grant date fair value of such equity awards and does not include any adjustments for failure to achieve the underlying vesting conditions or changes in our stock price. Amounts shown below as “compensation actually paid” do not reflect what was actually paid to or realized by our NEOs. Furthermore, these amounts are not taken into account by our Compensation Committee in making compensation decisions for our NEOs. For further information concerning our variable pay-for-performance philosophy and how we align executive compensation with the Company’s performance, please refer to the section of this proxy statement entitled “Compensation Discussion and Analysis —Executive Compensation Philosophy and Objectives.”


											Value of Initial Fixed $100 Investment Based on:(5)
Year(1)	Summary Compensation Table Total for PEO ($)(2)		Compensation Actually Paid to PEO ($)(3)			Average Summary Compensation Table Total for Non-PEO NEOs ($)(2)		Average Compensation Actually Paid to Non-PEO NEOs ($)(4)			Total Stockholder Return ($)		Peer Group Total Stockholder Return ($)		Net Income ($)			Revenue ($)(6)
2025		3,255,510		1,025,360			1,680,066		648,634			0.44		78.69		(81,653,000	)		119,476,000
2024		4,002,620		1,986,969			1,650,766		776,074			1.95		78.89		(127,976,000	)		113,689,000
2023		6,474,946		(742,679	)		2,120,417		269,676			9.52		74.82		(172,797,000	)		130,376,000
2022		4,128,283		(1,465,408	)		1,857,888		425,809			45.43		79.32		(162,956,000	)		115,375,000
2021		7,138,281		802,378			1,790,467		(1,356,955	)		81.09		103.50		(131,935,000	)		102,602,000

(1)

Leslie Trigg served as our principal executive officer (“PEO”) for the entirety of 2021, 2022, 2023, 2024 and 2025 and our other named executive officers for the applicable fiscal years were as follows:

2025: Renee Gaeta, John Brottem, Marc Nash and Nabeel Ahmed

2024: Nabeel Ahmed and John Brottem

2023: Nabeel Ahmed, John Brottem, Jean-Olivier Racine and Steve Williamson

2022: Nabeel Ahmed, John Brottem, Martin Vazquez and Steve Williamson

2021: Nabeel Ahmed, Rebecca Chambers, John Brottem, Jean-Olivier Racine and Martin Vazquez

(2)

Amounts reported in this column represent (i) the total compensation reported in the Summary Compensation Table for the applicable fiscal year in the case of our PEO and (ii) the average of the total compensation reported in the Summary Compensation Table for the applicable fiscal year for our named executive officers for the applicable fiscal year other than the PEO for such years.

(3)

Amounts reported in this column represent the compensation actually paid to our PEO in the indicated fiscal years, based on her total compensation reported in the Summary Compensation Table for the indicated fiscal years and adjusted as shown in the table below:


		PEO
		2025 ($)			2024 ($)			2023 ($)			2022 ($)			2021 ($)
	Summary Compensation Table - Total Compensation(a)		3,255,510			4,002,620			6,474,946			4,128,283			7,138,281
-	Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year(b)		(2,197,882	)		(2,400,223	)		(5,254,876	)		(2,904,800	)		(5,600,575	)
+	Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year(c)		340,017			488,450			713,379			1,963,877			4,874,562
+	Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years(d)		9,622			(238,222	)		(2,126,911	)		(2,894,318	)		(1,357,052	)
+	Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year(e)		—			489,876			—			—			—
+	Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year(f)		77,303			(355,531	)		(549,217	)		(1,758,449	)		(4,252,838	)
-	Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year(g)		(459,211	)		—			—			—			—
=	Compensation Actually Paid		1,025,360			1,986,969			(742,679	)		(1,465,408	)		802,378

(a)

Represents Total Compensation as reported in the Summary Compensation Table for the indicated fiscal year.

(b)

Represents the aggregate grant date fair value of the option awards and stock awards granted to our PEO during the indicated fiscal year, computed in accordance with ASC 718.

(c)

Represents the aggregate fair value as of the indicated fiscal year-end of our PEO’s outstanding and unvested option awards and stock awards granted during such fiscal year, computed in accordance with ASC 718. For awards subject to performance-based vesting conditions, the value set forth herein is based on the probable outcome of such performance-based vesting conditions as of the last day of the fiscal year.

(d)

Represents the aggregate change in fair value during the indicated fiscal year of the outstanding and unvested option awards and stock awards held by our PEO as of the last day of the indicated fiscal year and granted in a prior fiscal year, computed in accordance with ASC 718 and, for awards subject to performance-based vesting conditions, based on the probable outcome of such performance-based vesting conditions as of the last day of the fiscal year.

(e)

Represents the aggregate fair value at vesting of the option awards and stock awards that were granted to our PEO and vested during the indicated fiscal year, computed in accordance with ASC 718.

(f)

Represents the aggregate change in fair value, measured from the prior fiscal year-end to the vesting date, of each option award and stock award held by our PEO that was granted in a prior fiscal year and which vested during the indicated fiscal year, computed in accordance with ASC 718.

(g)

Represents the aggregate fair value as of the last day of the prior fiscal year of our PEO’s option awards and stock awards that were granted in a prior fiscal year and which failed to meet the applicable vesting conditions in the indicated fiscal year, computed in accordance with ASC 718.

(4)

Amounts reported in this column represent the compensation actually paid to the Company’s named executive officers other than our PEO in the indicated fiscal year, based on the average total compensation for such named executive officers reported in the Summary Compensation Table for the indicated fiscal year and adjusted as shown in the table below:


		Other Named Executive Officers Average(a)
		2025 ($)			2024 ($)			2023 ($)			2022 ($)			2021 ($)
	Summary Compensation Table - Total Compensation(b)		1,680,066			1,650,766			2,120,417			1,857,888			1,790,467
-	Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year(c)		(1,170,969	)		(942,736	)		(1,511,218	)		(1,175,932	)		(1,269,394	)
+	Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year(d)		227,878			215,616			285,115			826,328			931,355
+	Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years(e)		(14,518	)		(74,611	)		(403,901	)		(612,082	)		(203,933	)
+	Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year(f)		—			38,915			—			—			—
+	Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year(g)		15,683			(111,876	)		(220,737	)		(464,855	)		(959,759	)
-	Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year(h)		(89,506	)		—			—			(5,538	)		(1,645,691	)
=	Compensation Actually Paid		648,634			776,074			269,676			425,809			(1,356,955	)

(a)

Please see footnote 1 for the named executive officers included in the average for each indicated fiscal year.

(b)

Represents the average Total Compensation as reported in the Summary Compensation Table for the reported named executive officers in the indicated fiscal year.

(c)

Represents the average aggregate grant date fair value of the option awards and stock awards granted to the reported named executive officers during the indicated fiscal year, computed in accordance with ASC 718.

(d)

Represents the average aggregate fair value as of the indicated fiscal year-end of the reported named executive officers’ outstanding and unvested option awards and stock awards granted during such fiscal year, computed in accordance with ASC 718. For awards subject to performance-based vesting conditions, the value set forth herein is based on the probable outcome of such performance-based vesting conditions as of the last day of the fiscal year.

(e)

Represents the average aggregate change in fair value during the indicated fiscal year of the outstanding and unvested option awards and stock awards held by the reported named executive officers as of the last day of the indicated fiscal year and granted in a prior fiscal year, computed in accordance with ASC 718 and, for awards subject to performance-based vesting conditions, based on the probable outcome of such performance-based vesting conditions as of the last day of the fiscal year.

(f)

Represents the average aggregate fair value at vesting of the option awards and stock awards that were granted to the reported named executive officers and vested during the indicated fiscal year, computed in accordance with ASC 718.

(g)

Represents the average aggregate change in fair value, measured from the prior fiscal year-end to the vesting date, of each option awards and stock award held by the reported named executive officers that was granted in a prior fiscal year and which vested during the indicated fiscal year, computed in accordance with ASC 718.

(h)

Represents the average aggregate fair value as of the last day of the prior fiscal year of the reported named executive officers’ option awards and stock awards that were granted in a prior fiscal year and which failed to meet the applicable vesting conditions in the indicated fiscal year, computed in accordance with ASC 718.

(5)

These columns compare the total cumulative stockholder return on our common stock (under “Total Stockholder Return”) with the total return for the S&P Healthcare Equipment Select Industry Index (“SPSIHE”), a published index that includes companies in the healthcare equipment industry (under “Peer Group Total Stockholder Return”). Pursuant to the rules of the SEC, the comparison assumes $100 was invested in our common stock on December 31, 2020 and its relative performance is tracked through December 31, 2025, the last trading day of our most recent fiscal year. All values assume reinvestment of the full amount of all dividends, however no dividends have been declared on our common stock to date. Note that historic stock price performance is not necessarily indicative of future stock price performance.

(6)

The Compensation Committee selected revenue as the “Company Selected Measure” for purposes of this table. As reflected below in the section entitled “List of Performance Measures,” we used multiple financial performance measures to link compensation actually paid to the NEOs for 2025. The Compensation Committee determined the most important of these financial performance measures for 2025 to be revenue, as one of the two equal-weighted corporate performance goals under our annual cash bonus program, and a core driver of the Company’s performance, growth and stockholder value creation.

Company Selected Measure Name

revenue

Named Executive Officers, Footnote

(1)

2025: Renee Gaeta, John Brottem, Marc Nash and Nabeel Ahmed

2024: Nabeel Ahmed and John Brottem

2023: Nabeel Ahmed, John Brottem, Jean-Olivier Racine and Steve Williamson

2022: Nabeel Ahmed, John Brottem, Martin Vazquez and Steve Williamson

2021: Nabeel Ahmed, Rebecca Chambers, John Brottem, Jean-Olivier Racine and Martin Vazquez

Peer Group Issuers, Footnote

PEO Total Compensation Amount

$ 3,255,510

$ 4,002,620

$ 6,474,946

$ 4,128,283

$ 7,138,281

PEO Actually Paid Compensation Amount

$ 1,025,360

1,986,969

(742,679)

(1,465,408)

802,378

Adjustment To PEO Compensation, Footnote

(3)


		PEO
		2025 ($)			2024 ($)			2023 ($)			2022 ($)			2021 ($)
	Summary Compensation Table - Total Compensation(a)		3,255,510			4,002,620			6,474,946			4,128,283			7,138,281
-	Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year(b)		(2,197,882	)		(2,400,223	)		(5,254,876	)		(2,904,800	)		(5,600,575	)
+	Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year(c)		340,017			488,450			713,379			1,963,877			4,874,562
+	Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years(d)		9,622			(238,222	)		(2,126,911	)		(2,894,318	)		(1,357,052	)
+	Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year(e)		—			489,876			—			—			—
+	Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year(f)		77,303			(355,531	)		(549,217	)		(1,758,449	)		(4,252,838	)
-	Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year(g)		(459,211	)		—			—			—			—
=	Compensation Actually Paid		1,025,360			1,986,969			(742,679	)		(1,465,408	)		802,378

(a)

Represents Total Compensation as reported in the Summary Compensation Table for the indicated fiscal year.

(b)

Represents the aggregate grant date fair value of the option awards and stock awards granted to our PEO during the indicated fiscal year, computed in accordance with ASC 718.

(c)

(d)

(e)

Represents the aggregate fair value at vesting of the option awards and stock awards that were granted to our PEO and vested during the indicated fiscal year, computed in accordance with ASC 718.

(f)

(g)

Non-PEO NEO Average Total Compensation Amount

$ 1,680,066

1,650,766

2,120,417

1,857,888

1,790,467

Non-PEO NEO Average Compensation Actually Paid Amount

$ 648,634

776,074

269,676

425,809

(1,356,955)

Adjustment to Non-PEO NEO Compensation Footnote

(4)


		Other Named Executive Officers Average(a)
		2025 ($)			2024 ($)			2023 ($)			2022 ($)			2021 ($)
	Summary Compensation Table - Total Compensation(b)		1,680,066			1,650,766			2,120,417			1,857,888			1,790,467
-	Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year(c)		(1,170,969	)		(942,736	)		(1,511,218	)		(1,175,932	)		(1,269,394	)
+	Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year(d)		227,878			215,616			285,115			826,328			931,355
+	Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal Years(e)		(14,518	)		(74,611	)		(403,901	)		(612,082	)		(203,933	)
+	Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year(f)		—			38,915			—			—			—
+	Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year(g)		15,683			(111,876	)		(220,737	)		(464,855	)		(959,759	)
-	Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year(h)		(89,506	)		—			—			(5,538	)		(1,645,691	)
=	Compensation Actually Paid		648,634			776,074			269,676			425,809			(1,356,955	)

(a)

Please see footnote 1 for the named executive officers included in the average for each indicated fiscal year.

(b)

Represents the average Total Compensation as reported in the Summary Compensation Table for the reported named executive officers in the indicated fiscal year.

(c)

(d)

(e)

(f)

(g)

(h)

Compensation Actually Paid vs. Total Shareholder Return

Compensation Actually Paid vs. Net Income

Compensation Actually Paid vs. Company Selected Measure

Tabular List, Table

The following table includes a list of financial performance measures which, in the Company’s assessment, represent the most important financial performance measures used by the Company to link compensation actually paid to the NEOs to Company performance for 2025. More information about the ways in which these measures were integrated into the Company’s annual cash bonus and long-term equity incentive programs is included in the Compensation Discussion and Analysis section of this proxy statement.

       PERFORMANCE MEASURES:

      

       ✓Revenue
✓Operating income (non-GAAP)
✓EBITDA (non-GAAP)
✓Relative TSR compared to Russell 2000 Medical Device Index
✓Stock price

      

Total Shareholder Return Amount

$ 0.44

1.95

9.52

45.43

81.09

Peer Group Total Shareholder Return Amount

78.69

78.89

74.82

79.32

103.5

Net Income (Loss)

$ (81,653,000)

$ (127,976,000)

$ (172,797,000)

$ (162,956,000)

$ (131,935,000)

Company Selected Measure Amount

119,476,000

113,689,000

130,376,000

115,375,000

102,602,000

PEO Name

Leslie Trigg

Measure:: 1

Revenue

Measure:: 2

Operating income (non-GAAP)

Measure:: 3

EBITDA (non-GAAP)

Measure:: 4

Relative TSR compared to Russell 2000 Medical Device Index

Measure:: 6

PEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table

Stock price

PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested

$ (2,197,882)

$ (2,400,223)

$ (5,254,876)

$ (2,904,800)

$ (5,600,575)

PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested

340,017

488,450

713,379

1,963,877

4,874,562

PEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year

9,622

(238,222)

(2,126,911)

(2,894,318)

(1,357,052)

PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year

489,876

PEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year

77,303

(355,531)

(549,217)

(1,758,449)

(4,252,838)

Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table

(459,211)

Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested

(1,170,969)

(942,736)

(1,511,218)

(1,175,932)

(1,269,394)

Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested

227,878

215,616

285,115

826,328

931,355

Non-PEO NEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year

(14,518)

(74,611)

(403,901)

(612,082)

(203,933)

Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year

38,915

Non-PEO NEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year

15,683

(111,876)

(220,737)

(464,855)

(959,759)